Table 1 Demographic information by initial chemotherapy regimen with regard to age, stage, debulking surgery, and radiation
Demographic | All | No chemo | Carboplatin/ Paclitaxel | Ifosfamide/ Paclitaxel | Other Platinum | p-value |
|---|---|---|---|---|---|---|
Total N | 31 | 3 (10%) | 15 (48%) | 7 (23%) | 6 (19%) | |
Mean age at diagnosis (yrs ± St dev.) | 65.39 ± 11.3 | 70.67 ± 7.6 | 68.33 ± 11.3 | 59.29 ± 4.4 | 62.50 ± 16.1 | 0.257 |
STAGE | ||||||
Stage IC-II | 7 (22.6%) | 0 (0%) | 4 (26.7%) | 2 (28.6%) | 1 (16.7%) | 0.736 |
Stage III | 21 (67.7%) | 3 (100%) | 9 (60%) | 4 (57.1%) | 5 (83.3%) | |
Stage IV | 3 (9.7%) | 0 (0%) | 2 (13.3%) | 1 (12.3%) | 0 (0%) | |
DEBULKING STATUS | ||||||
Debulking Surgery | 29 (93.5%) | 3 (100%) | 14 (93.3%) | 6 (85.7%) | 6 (100%) | 0.562 |
Optimal debulking | 19 (61.3%) | 1 (33.3%) | 10 66.7%) | 4 (57.1%) | 4 (66.6%) | |
Suboptimal debulking | 9 (29.0%) | 2 (66.7%) | 4 (26.6%) | 2 (28.6%) | 1 (16.7%) | |
Unknown Status | 1 (3.2%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (16.7%) | |
No Surgery Attempted | 2 (6.5%) | 0 (0%) | 1 (6.7%) | 1 (14.3%) | 0 (0%) | |
Radiation | 1 | 0 | 0 | 0 | 1 | NA |